keyword
Keywords Management.,chemotherapy,side ...

Management.,chemotherapy,side effects

https://read.qxmd.com/read/38577344/case-report-and-literature-review-of-rezvilutamide-in-the-treatment-of-hormone-sensitive-prostate-cancer
#21
Chunlei Zhang, Jie Ren, Yindong Kang, Dehui Chang
BACKGROUND: Prostate cancer represents a major health concern worldwide, with the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) and locally advanced prostate cancer posing a particular challenge. Rezvilutamide, a new androgen receptor antagonist from China, has shown early promise; however, its real-world effectiveness and safety profile require further evidence. This case series evaluates the preliminary clinical outcomes of rezvilutamide in combination with androgen deprivation therapy (ADT), focusing on PSA response and radiological findings across various stages of prostate cancer in four patients...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38574043/changes-in-lymph-node-surgery-in-breast-cancer-and-preoperative-drug-prescription-analysis-for-postoperative-pain-management-a-retrospective-cross-sectional-study
#22
JOURNAL ARTICLE
Eun Sol Kang, Yu-Cheol Lim, Bo-Hyoung Jang, Yoon Jae Lee, In-Hyuk Ha, Ye-Seul Lee
This study aimed to investigate the changes in lymph node surgery types and prescription patterns of postoperative medications for pain management in patients with breast cancer using national health insurance claim data from South Korea. The study population comprised patients with at least one record of a principal diagnosis of breast cancer (ICD-10 code: C50) from the national health insurance claim database between 2010 and 2019. Patients who underwent mastectomy or lumpectomy only once were selected for the analysis...
2024: PloS One
https://read.qxmd.com/read/38571509/high-costs-low-quality-of-life-reduced-survival-and-room-for-improving-treatment-an-analysis-of-burden-and-unmet-needs-in-glioma
#23
REVIEW
Johannes Pöhlmann, Michael Weller, Andrea Marcellusi, Kristin Grabe-Heyne, Lucia Krott-Coi, Silvia Rabar, Richard F Pollock
Gliomas are a group of heterogeneous tumors that account for substantial morbidity, mortality, and costs to patients and healthcare systems globally. Survival varies considerably by grade, histology, biomarkers, and genetic alterations such as IDH mutations and MGMT promoter methylation, and treatment, but is poor for some grades and histologies, with many patients with glioblastoma surviving less than a year from diagnosis. The present review provides an introduction to glioma, including its classification, epidemiology, economic and humanistic burden, as well as treatment options...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38547003/plain-language-summary-of-the-transform-study-primary-analysis-results-liso-cell-as-a-second-treatment-regimen-for-large-b-cell-lymphoma-following-failure-of-the-first-treatment-regimen
#24
REVIEW
Jeremy S Abramson, Scott R Solomon, Jon Arnason, Patrick B Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi, Stephan Mielke, Pim Mutsaers, Francisco Hernandez-Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew Lunning, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Ken Ogasawara, Manali Kamdar
WHAT IS THIS SUMMARY ABOUT?: People diagnosed with a disease called large B-cell lymphoma (LBCL) may experience return, or early relapse, of their disease within the first year after receiving and responding to their first (first-line) treatment regimen. Others may have primary refractory disease, meaning that the disease either did not respond to first-line treatment at all or only responded for a very brief period. Second (second-line) treatment includes immunotherapy followed by high-dose chemotherapy and ASCT, which has the potential to cure LBCL...
March 28, 2024: Future Oncology
https://read.qxmd.com/read/38544901/structure-activity-relationship-of-anticancer-drug-candidate-quinones
#25
JOURNAL ARTICLE
Nadire Özenver, Neslihan Sönmez, Merve Yüzbaşioğlu Baran, Merve Yüzbaşioğlu Baran, Ayşe Uz, Lütfiye Ömür Demirezer
Breast cancer is one of the most prevalent cancer types worldwide. Chemotherapy is a substantial approach in the management of breast cancer despite the occurrence of chemotherapy-associated side effects and the development of multidrug resistance in cancer cells. At this point, a variety of quinone derivatives may represent potential as possible anticancer drug candidates due to possessing structural similarity towards clinically used anticancer drugs like doxorubicin. Therefore, we investigated the cytotoxic effects of various quinone derivatives with structural diversity towards a variety of breast cancer cells...
2024: Turkish Journal of Chemistry
https://read.qxmd.com/read/38543308/synthesis-and-characterization-of-zif-90-nanoparticles-as-potential-brain-cancer-therapy
#26
JOURNAL ARTICLE
Lorenzo Monarca, Francesco Ragonese, Paola Sabbatini, Concetta Caglioti, Matteo Stamegna, Federico Palazzetti, Paolo Sportoletti, Ferdinando Costantino, Bernard Fioretti
Human glioblastoma is probably the most malignant and aggressive among cerebral tumors, of which it represents approximately 80% of the reported cases, with an overall survival rate that is quite low. Current therapies include surgery, chemotherapy, and radiotherapy, with associated consistent side effects and low efficacy. The hardness in reaching the site of action, and overcoming the blood-brain barrier, is a major limitation of pharmacological treatments. In this paper, we report the synthesis and characterization of ZIF-90 (ZIF, Zeolitic Imidazolate Framework) nanoparticles as putative carriers of anticancer drugs to the brain...
March 18, 2024: Pharmaceutics
https://read.qxmd.com/read/38541316/quality-of-life-and-associated-factors-among-cancer-patients-receiving-chemotherapy-during-the-covid-19-pandemic-in-thailand
#27
JOURNAL ARTICLE
Porawan Witwaranukool, Ratchadapa Seedadard, Suphanna Krongthaeo, Yosapon Leaungsomnapa
The dynamics of the COVID-19 pandemic have significantly changed since its initial outbreak. This study aimed to investigate the quality of life (QoL) of patients with cancer receiving chemotherapy in the specific context of Thailand during the COVID-19 pandemic. A cross-sectional study was conducted with 415 patients with cancer. Instruments used were a demographic and clinical characteristics form, the Edmonton Symptom Assessment Scale (cancer symptom burden), Strategies Used by People to Promote Health (self-care self-efficacy), and a Thai version of the Brief Form of the WHO Quality of Life Assessment...
March 9, 2024: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/38518690/effect-of-peppermint-inhalation-versus-swedish-massage-on-chemotherapy-induced-nausea-and-vomiting-in-children-with-leukemia-multi-arm-randomised-trial-design
#28
JOURNAL ARTICLE
Eman Arafa Badr, Hawaa Mohamed Abdalla, Yousr Abd-Elsalam Gaafer, Maha Youssef Kamel
BACKGROUND: Chemotherapy is the foremost treatment for children with leukemia, while causing different serious side-effects. Chemotherapy-induced nausea and vomiting are the most common deliberating side effects and critical concerns of pediatric oncology nurses among those children. AIM: To investigate the effect of peppermint inhalation versus Swedish massage on chemotherapy-induced nausea and vomiting in children with leukemia. DESIGN: A multi-arm randomised trial design with three parallel groups...
March 21, 2024: Journal of Pediatric Nursing
https://read.qxmd.com/read/38516472/nephrological-detrimental-impacts-resulting-from-novel-immunotherapy-drugs-used-in-the-treatment-of-cancer-a-systematic-review
#29
REVIEW
Amisha Jaiswal, Kainaat Shergill, Kusalik Boppana, Naiela E Almansouri, Saloni Bakkannavar, Youmna Faheem, Tuheen Sankar Nath
The most recent advancements in cancer therapy center on efficiently and conveniently enhancing a patient's natural immune system. Immune checkpoint inhibitors (ICIs) are antibodies that target cytotoxic thymus (T) lymphocyte antigen-4 (CTLA-4) and its receptor. They function by stimulating T-cell activity against malignancies. Immune-related adverse events (irAEs) are a distinct class of inflammatory side effects that are specific to a given organ. Antineoplastic medications can impact any part of the kidney, leading to the development of proteinuria, hypertension, electrolyte abnormalities, glomerulonephritis, and both acute and chronic interstitial nephritis...
February 2024: Curēus
https://read.qxmd.com/read/38514507/early-detection-of-occupational-cholangiocarcinoma-in-a-high-risk-patient-under-intensive-surveillance-a-case-study
#30
JOURNAL ARTICLE
Naoko Kounami, Sakae Maeda, Akihiro Kitagawa, Hideo Tomihara, Yuki Ushimaru, Nobuyoshi Ohara, Tomohira Takeoka, Mitsunobu Imasato, Ryohei Kawabata, Shingo Noura, Yumiko Yasuhara, Atsushi Miyamoto
BACKGROUND: Occupational cholangiocarcinoma is associated with exposure to organic solvents, such as dichloromethane (DCM) and 1,2-dichloropropane (DCP). This report describes a case of occupational cholangiocarcinoma detected through regularly imaging following the discovery of elevated serum γ-glutamyl trans peptidase (γ-GTP) levels revealed during regular checkup. CASE PRESENTATION: A 43-year-old man who had been working in a printing company with 15 years of exposure to organic solvents presented to our hospital owing to abnormalities found during a routine checkup...
March 22, 2024: Surgical Case Reports
https://read.qxmd.com/read/38509339/advanced-interventional-treatments-in-retinoblastoma-management-a-comprehensive-review
#31
REVIEW
Peter Kolyvas, Aazrin Mir, Thomas Stirrat, Brittany Brookner, Nathanael Pilar, Eric Monroe, Rakesh Ahuja
Retinoblastoma is the most common eye malignancy in children that if left untreated can invade intraocular structures, metastasize, and rarely lead to death. Traditionally treated with systemic chemotherapy, Intra-arterial chemotherapy is gaining popularity as it allows for the direct administration of chemotherapy through the ophthalmic artery, thus reducing systemic side effects. Intra-arterial chemotherapy procedures have evolved, with refinements to reduce risks and radiation exposure. Intra-arterial chemotherapy boasts an impressive technical success rate and one year ocular survival even amongst advanced cases...
April 2024: Cardiovascular and Interventional Radiology
https://read.qxmd.com/read/38504770/bevacizumab-induced-pulmonary-cystic-disease
#32
Dakota McNierney, Fahed Owda, Hamza A Salim, Shatha M A Mallah, Jehad Azar
The use of Bevacizumab has significantly advanced the treatment of various malignancies. Bevacizumab's inhibition of angiogenesis is a known mechanism that impedes tumour growth and facilitates chemotherapy delivery; however, its association with the development of cystic lung disease is not fully understood. We report a unique case of a 73-year-old woman with a past medical history of metastatic endometrial adenocarcinoma status post-chemotherapy with bevacizumab that presented with worsening respiratory symptoms...
March 2024: Respirology Case Reports
https://read.qxmd.com/read/38503158/treatment-of-recurrent-malignant-pheochromocytoma-with-a-novel-approach-a-case-report-and-review-of-literature
#33
Marwan Alaswad, Belal Nedal Sabbah, Mohamed Umair Aleem, Rania Naguib, Ayman Z Azzam, Tarek M Amin
INTRODUCTION: Pheochromocytomas are rare catecholamine-secreting tumors with a high potential for recurrence post-surgery, necessitating prolonged follow-up. This case highlights the diagnostic and therapeutic challenges in managing recurrent pheochromocytoma. CASE PRESENTATION: A 25-year-old female, with a history of left pheochromocytoma treated with adrenalectomy a decade earlier, presented with a right adrenal mass. Despite controlled hypertension, elevated urine metanephrines suggested recurrence...
March 11, 2024: International Journal of Surgery Case Reports
https://read.qxmd.com/read/38502556/conservative-non-pharmacological-treatments-for-chemotherapy-induced-peripheral-neuropathies-in-women-treated-for-breast-cancer-a-systematic-review
#34
JOURNAL ARTICLE
Gianpaolo Ronconi, Dario M Gatto, Sefora Codazza, Mariantonietta Ariani, Eloisa Martire, Luca Cerretti, Valentina Carella, Daniele Coraci, Giorgio Ferriero, Paola E Ferrara
INTRODUCTION: Over the last few decades, the use of neo/adjuvant therapies has significantly increased the number of breast cancer survivors who experience chemotherapy-induced peripheral neuropathy (CIPN). To date, few, low-efficacy, pharmacological remedies exist to manage this side effect. For this reason, alternative treatments are increasingly being investigated as possible strategies to prevent or promote faster recovery from CIPN. In this review we aimed to provide an overview of the literature evidence regarding all the non-pharmacological and rehabilitative interventions for patients affected by CIPN secondary to breast cancer care...
March 19, 2024: European Journal of Physical and Rehabilitation Medicine
https://read.qxmd.com/read/38502472/safety-and-efficacy-of-atezolizumab-plus-bevacizumab-combination-therapy-in-patients-with-unresectable-hepatocellular-carcinoma-undergoing-dialysis-a-case-series
#35
JOURNAL ARTICLE
Koki Sakaguchi, Tatsunori Satoh, Shinya Kawaguchi, Takuya Aoyama, Kazuhisa Asahara, Shinya Endo, Naofumi Shirane, Hideyuki Kanemoto, Noriyuki Oba, Kazuya Ohno
Three patients aged 79, 75, and 81 years with unresectable hepatocellular carcinoma (HCC) and undergoing maintenance hemodialysis were treated with a combination of atezolizumab and bevacizumab. The patients, respectively, received their 22nd, 2nd, and 4th treatment cycles, and one achieved long-term stable disease. No serious adverse events, including immune-related adverse events, were observed in any patient. Remarkable progress has been made in chemotherapy for cancer; however, the efficacy and safety of chemotherapy in patients undergoing hemodialysis have not been adequately elucidated...
March 19, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38501631/onycholysis-as-a-complication-of-taxane-based-chemotherapy-with-concomitant-cryotherapy-in-breast-cancer-patients-two-case-reports
#36
JOURNAL ARTICLE
N Chikhladze, N Chelidze, S Kordzaia, M Zhvania, L Khmaladze
Nail changes are a common side effect of taxane chemotherapy, although onycholysis is quite a rare complication the correct management of which is poorly standardized. These case reports provide a description and analysis of onycholysis, a rare but noteworthy complication observed during taxane-based chemotherapy with concomitant cryotherapy in two patients with breast cancer. Despite prophylactic measures, both cases experienced nail complications during Paclitaxel treatment, underlining the complex nature of onycholysis during taxane therapy and highlighting the critical role of nail assessment and infection screening...
January 2024: Georgian Medical News
https://read.qxmd.com/read/38501053/immune-related-adverse-event-related-adrenal-insufficiency-mediates-immune-checkpoint-inhibitors-efficacy-in-cancer-treatment
#37
JOURNAL ARTICLE
Shasha Zhang, Jianhua Wu, Yue Zhao, Jingjing Zhang, Xiaoyun Zhang, Chensi Wu, Zhidong Zhang, Zhanjun Guo
PURPOSE: Immune checkpoint inhibitors (ICIs) have significantly improved the outcomes of patients with cancer; however, these agents may initiate immune-related adverse events (irAEs). Previous studies have demonstrated a robust correlation between disease prognosis and the occurrence of irAEs, specifically skin or endocrine irAEs. Herein, we aimed to evaluate the correlation between irAE-related adrenal insufficiency (AI) and ICI treatment efficacy. PATIENTS AND METHODS: Patients diagnosed with gastrointestinal, respiratory, head and neck, urological, skin and gynecologic cancers treated with anti-programmed cell death 1 (PD-1)/anti-programmed cell death ligand 1 (PD-L1) antibody as monotherapy or combined therapy (combined with chemotherapy or targeted therapy) were divided into irAE-A (patients with irAE-related AI), irAE-B (patients with other irAEs) and non-irAE groups...
2024: Cancer Management and Research
https://read.qxmd.com/read/38496704/single-port-video-assisted-thoracoscopic-sleeve-lobectomy-after-neoadjuvant-immunochemotherapy-a-case-report
#38
Hao Chen, Jiarong Zhang, Antonio Rossi, Duilio Divisi, Chun Chen, Bin Zheng
BACKGROUND: The morbidity and mortality of lung cancer have always ranked first among malignant tumors (MTs). Previous studies have shown that neoadjuvant chemotherapy can improve the 5-year survival rate of patients with non-small cell lung cancer (NSCLC), but the benefit is limited. Studies have proven that neoadjuvant immunotherapy combined with chemotherapy has unique advantages in prolonging patient survival, reducing distant recurrence, and inducing antitumor immunity. However, its impact remains to be more comprehensively investigated...
February 29, 2024: Translational Lung Cancer Research
https://read.qxmd.com/read/38492161/a-comprehensive-overview-on-chemotherapy-induced-cardiotoxicity-insights-into-the-underlying-inflammatory-and-oxidative-mechanisms
#39
REVIEW
András Nagy, Denise Börzsei, Alexandra Hoffmann, Szilvia Török, Médea Veszelka, Nikoletta Almási, Csaba Varga, Renáta Szabó
While oncotherapy has made rapid progress in recent years, side effects of anti-cancer drugs and treatments have also come to the fore. These side effects include cardiotoxicity, which can cause irreversible cardiac damages with long-term morbidity and mortality. Despite the continuous in-depth research on anti-cancer drugs, an improved knowledge of the underlying mechanisms of cardiotoxicity are necessary for early detection and management of cardiac risk. Although most reviews focus on the cardiotoxic effect of a specific individual chemotherapeutic agent, the aim of our review is to provide comprehensive insight into various agents that induced cardiotoxicity and their underlying mechanisms...
March 16, 2024: Cardiovascular Drugs and Therapy
https://read.qxmd.com/read/38488996/effects-of-aromatherapy-on-physical-and-mental-health-of-cancer-patients-undergoing-radiotherapy-and-or-chemotherapy-a-meta-analysis
#40
JOURNAL ARTICLE
Shuang-Ran Xie, Liang Ma, Xin-Yu Xu, Shu Zhou, Hui-Miao Xie, Chang-Sheng Xie
BACKGROUP: Currently, aromatherapy is being increasingly utilized in clinical practice, particularly in managing the side effects associated with radiotherapy and chemoradiotherapy. However, it remains to be established whether aromatherapy can effectively alleviate these symptoms. OBJECTIVE: To investigate the effects of aromatherapy on the physical and mental health of patients with cancer undergoing radiotherapy and chemotherapy. METHODS: Seven databases were researched from inception until September 29, 2023, including PubMed, Scopus, and Web of Science, Chinese National Knowledge Infrastructure, Wanfang database, China Biology Medicine disc and VIP Chinese Medical Journal Database...
March 15, 2024: Chinese Journal of Integrative Medicine
keyword
keyword
12496
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.